SAN DIEGO, Oct. 8, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will i

In a rare disease research dataset, SpliceAI2 identified 17% more disease-relevant variants compared

Barclays analyst Luke Sergott maintains Illumina (NASDAQ:ILMN) with a Underweight and raises the

Illumina, Inc. (NASDAQ: ILMN - Get Free Report) has earned a consensus rating of "Hold" from the eig

Argent Capital Management LLC purchased a new position in shares of Illumina, Inc. (NASDAQ: ILMN) du

RBC Capital analyst Dan Leonard maintains Illumina (NASDAQ:ILMN) with a Outperform and raises the

Guggenheim analyst Subbu Nambi maintains Illumina (NASDAQ:ILMN) with a Buy and raises the price t

Illumina, Inc. (NASDAQ: ILMN - Get Free Report) shares hit a new 52-week high on Tuesday. The compan

Strong performance across the healthtech sector over the past two quarters has sparked renewed marke

Illumina (ILMN +0.04%) is building a deeper AI strategy around the biological data created by its se

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Regeneron

Leerink Partners analyst Puneet Souda maintains Illumina (NASDAQ:ILMN) with a Outperform and rais

Investors need to pay close attention to ILMN stock based on the movements in the options market lat

Piper Sandler analyst David Westenberg maintains Illumina (NASDAQ:ILMN) with a Overweight and rai

Illumina, Inc. (NASDAQ: ILMN - Get Free Report) shares reached a new 52-week high during mid-day tra

ILMN's 94.9% YTD rally reflects strong sequencing growth, clinical adoption and a raised 2026 outloo

Louis says buy the AI dip

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 5.48% on an annualized

RBC initiated coverage of Grail with a Sector Perform rating and $84 target, citing Galleri’s potent

On Thursday, Illumina (NASDAQ:ILMN) discussed second-quarter financial results during its earnings c

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 4.87% on an annualized

U.S. stocks mixed as Nasdaq rises; LuxExperience jumps 13.5% on strong sales, while Einride, Forgent

The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi p

Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Baird Financial Group Inc. lowered its stake in Illumina, Inc. (NASDAQ: ILMN) by 14.6% in the undefi

Analysts upgraded SFNC, OBIO, and more.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

Analysts upgraded Sagimet, Figure, Illumina, Martin Marietta and Waters, raising price targets and i

UBS analyst Doug Schenkel upgrades Illumina (NASDAQ:ILMN) from Neutral to Buy and raises the pric

The S&P 500 is set for another shakeup, with Bloom Energy (BE), Everpure (P), and Illumina (ILMN) al

Genomics is reshaping healthcare, with WGS, NEO and NTLA advancing diagnostics and precision medicin

Illumina (ILMN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the co

NEW YORK, Sept. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the

AI energy play Bloom Energy will be added to the S&P 500 index on Sept. 21. Illumina and Everpure al

https://www.spglobal.com/spdji/en//documents/indexnews/announcements/20260904-1484999/1484999_shuffl

Argus Research analyst Jasper Hellweg maintains Illumina (NASDAQ:ILMN) with a Buy and raises the

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 4.32% on an annualized

Long-end Treasury yields snapped back toward 20-month highs; Walmart posted its worst session in fou

Dow Jones down 300 points, Deere & Co shares up 7.9% after beating earnings expectations. SCTX,

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 3.84% on an annualized

Canaccord Genuity analyst Kyle Mikson maintains Illumina (NASDAQ:ILMN) with a Hold and raises the

Citigroup analyst Joanne Wuensch maintains Illumina (NASDAQ:ILMN) with a Sell and raises the pric

Piper Sandler analyst David Westenberg reiterates Illumina (NASDAQ:ILMN) with a Overweight and ra

RBC Capital analyst Dan Leonard maintains Illumina (NASDAQ:ILMN) with a Outperform and raises the

JP Morgan analyst Casey Woodring maintains Illumina (NASDAQ:ILMN) with a Overweight and raises th

TD Cowen analyst Dan Brennan maintains Illumina (NASDAQ:ILMN) with a Hold and raises the price ta

Guggenheim analyst Subbu Nambi maintains Illumina (NASDAQ:ILMN) with a Buy and raises the price t

Stifel analyst Daniel Arias maintains Illumina (NASDAQ:ILMN) with a Buy and raises the price targ

Barclays analyst Luke Sergott maintains Illumina (NASDAQ:ILMN) with a Underweight and raises the